HDAC6 is a microtubule-associated deacetylase
The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Reversible acetylation of alpha-tubulin has been implicated in regulating microtubule stability and function. The distribution of acetylated alpha-tubulin is tightly controlled and stereotypic. Acetylated alpha-tubulin is most abundant in stable microtubules but is absent from dynamic cellular structures such as neuronal growth cones and the leading edges of fibroblasts. However, the enzymes responsible for regulating tubulin acetylation and deacetylation are not known. Here we report that a member of the histone deacetylase family, HDAC6, functions as a tubulin deacetylase. HDAC6 is localized exclusively in the cytoplasm, where it associates with microtubules and localizes with the microtubule motor complex containing p150(glued) (ref. 3). In vivo, the overexpression of HDAC6 leads to a global deacetylation of alpha-tubulin, whereas a decrease in HDAC6 increases alpha-tubulin acetylation. In vitro, purified HDAC6 potently deacetylates alpha-tubulin in assembled microtubules. Furthermore, overexpression of HDAC6 promotes chemotactic cell movement, supporting the idea that HDAC6-mediated deacetylation regulates microtubule-dependent cell motility. Our results show that HDAC6 is the tubulin deacetylase, and provide evidence that reversible acetylation regulates important biological processes beyond histone metabolism and gene transcription.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“HDAC6 catalyzes the deacetylation of K40 in the α-tubulin subunit of the microtubule,24 thereby regulating microtubule dynamics”
From Histone deacetylase 6 structure and molecular basis of catalysis and inhibition (2016) · cites this paper as [24]
In the citing paper
“HDAC6, a tubulin deacetylase [24].”
From Elevated SGK1 increases Tau phosphorylation and microtubule instability in Alzheimer’s patient-derived cortical neurons (2026) · cites this paper as [24]
In the citing paper
“The histone deacetylase 6 (HDAC6) has also been implicated in tau deacetylation/acetylation [180].”
From Tau and neuroinflammation in Alzheimer’s disease: interplay mechanisms and clinical translation (2023) · cites this paper as [180]
In the citing paper
“HDAC6 was shown to be the deacetylase for a diverse set of substrates involved in tumourigenesis, such as HSP90, α-tubulin, cortactin and peroxiredoxins”
From A novel small molecule hydroxamate preferentially inhibits HDAC6 activity and tumour growth (2013) · cites this paper as Hubbert et al, 2002
In the citing paper
“HDAC6 knockout in mice does not lead to embryonic lethality”
From A novel small molecule hydroxamate preferentially inhibits HDAC6 activity and tumour growth (2013) · cites this paper as Hubbert et al, 2002
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Acetylation: a regulatory modification to rival phosphorylation?
Kouzarides, T. (2000) · The EMBO Journal · doi:10.1093/emboj/19.6.1176 · Cited by 1,160
Microtubules containing acetylated alpha-tubulin in mammalian cells in culture.
Piperno, G., LeDizet, M., & Chang, X. J. (1987) · The Journal of cell biology · doi:10.1083/jcb.104.2.289 · Cited by 873
Deacetylation of p53 modulates its effect on cell growth and apoptosis
Luo, J., Su, F., Chen, D., Shiloh, A., & Gu, W. (2000) · Nature · doi:10.1038/35042612 · Cited by 818
Three proteins define a class of human histone deacetylases related to yeast Hda1p
Grozinger, C. M., Hassig, C. A., & Schreiber, S. L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.9.4868 · Cited by 770 · cited 1×
“At least 11 proteins predicted to be members of the HDAC family have been identified on the basis of homology within the catalytic domai”
BackgroundPiperno, G., & Fuller, M. T. (1985) · The Journal of cell biology · doi:10.1083/jcb.101.6.2085 · Cited by 757
p300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2
Ito, A., Lai, C.-H., Zhao, X., Saito, S., Hamilton, M. H., Appella, E., & Yao, T.-P. (2001) · The EMBO Journal · doi:10.1093/emboj/20.6.1331 · Cited by 582
Self-citationMicrotubule Targeting of Substrate Contacts Promotes Their Relaxation and Dissociation
Kaverina, I., Krylyshkina, O., & Small, J. V. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.146.5.1033 · Cited by 480
Histone acetylation: chromatin in action
Wade, P. A., Pruss, D., & Wolffe, A. P. (1997) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(97)01016-5 · Cited by 471
Furumai, R., Komatsu, Y., Nishino, N., Khochbin, S., Yoshida, M., & Horinouchi, S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.1.87 · Cited by 412 · cited 1×
“Unlike other family members, HDAC6 is uniquely resistant to the potent HDAC inhibitors trapoxin-B (TPXb”
BackgroundSelf-citationRegulation of cytoplasmic dynein behaviour and microtubule organization by mammalian Lis1
Smith, D. S., Niethammer, M., Ayala, R., Zhou, Y., Gambello, M. J., Wynshaw-Boris, A., & Tsai, L.-H. (2000) · Nature Cell Biology · doi:10.1038/35041000 · Cited by 381
Cited by
Items 901–1,000 of 1,012
Regulation of Histone Deacetylase 6 Activity via S-Nitrosylation
Okuda, K., Ito, A., & Uehara, T. (2015) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b15-00364 · Cited by 46
Self-citationDual Inhibitors Against Topoisomerases and Histone Deacetylases
Seo, Y. H. (2015) · Journal of Cancer Prevention · doi:10.15430/jcp.2015.20.2.85 · Cited by 48
“HDACs regulate a dynamic epigenetic modification of the lysine on various proteins including histones, p53, E2F, α-tubulin, and Hsp90.”
BackgroundInfluentialHashimoto, A., Hirase, T., Asaka, M., & Node, K. (2011) · Hypertension Research · doi:10.1038/hr.2011.64 · Cited by 46
Epigenetic regulation of axon and dendrite growth
Trakhtenberg, E. F., & Goldberg, J. L. (2012) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2012.00024 · Cited by 51
“…neurite growth by epigenetically augmenting transcription, or by directly acetylating and regulating specific transcription factors, α-tubulin (Hubbert et al., 2002; Rivieccio et al., 2009; Kim et al., 2010; Tapia et al., 2010), or other proteins that also depend on some basal…”
BackgroundChen, C., Kelly, M., de Leon, J., Nwagbara, B. U., Ebbert, P. T., Ferguson, D. J. P., Lowery, L. A., Morrissette, N. S., & Gubbels, M. (2015) · Molecular Biology of the Cell · doi:10.1091/mbc.e15-06-0437 · Cited by 39
“, 2007) and in other systems has been shown to also deacetylate MTs (Hubbert et al., 2002).”
BackgroundLin, T.-W., Chen, M.-T., Lin, L., Huang, P., Lo, W., Yang, Y.-P., Lu, K., Chen, Y., Chiou, S., & Wu, C. (2017) · Oncotarget · doi:10.18632/oncotarget.17979 · Cited by 45
“Unlike type I HDACs, HDAC6 is categorized as type IIB HDAC and is mostly located in the cytoplasm, where it is predominantly engaged in cytoskeletal regulation [40, 41].”
BackgroundYan, Y., Wang, H., Hu, M., Jiang, L., Wang, Y., Liu, P., Liang, X., Liu, J., Li, C., Battle, A. L., et al. (2017) · Developmental Cell · doi:10.1016/j.devcel.2017.09.001 · Cited by 45
Chu-Farseeva, Y.-Y., Mustafa, N. B., Poulsen, A., Tan, E. C., Yen, J. J. Y., Chng, W. J., & Dymock, B. W. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.09.024 · Cited by 46
Lysine acetylation of cytoskeletal proteins: Emergence of an actin code
Mu, A., Latario, C. J., Pickrell, L. E., & Higgs, H. N. (2020) · The Journal of Cell Biology · doi:10.1083/jcb.202006151 · Cited by 48
de Freitas, N. L., Deberaldini, M. G., Gomes, D., Pavan, A. R., Sousa, Â., dos Santos, J. L., & Soares, C. P. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.592868 · Cited by 49
“The previous role of deacetylase attributed to HDAC6 seems to be shared by HDAC8, which suggests apparent functional redundancy (Hubbert et al., 2002).”
BackgroundHow Influenza Virus Uses Host Cell Pathways during Uncoating
Moreira, É. A., Yamauchi, Y., & Matthias, P. (2021) · Cells · doi:10.3390/cells10071722 · Cited by 55
Shan, M., Zou, Y., Pan, Z., Zhang, H., Xu, Y., Ju, J., & Sun, S. (2022) · Development · doi:10.1242/dev.200231 · Cited by 50
Molecular mechanisms of histone deacetylases and inhibitors in renal fibrosis progression
Wang, J., Li, J., Zhang, X., Zhang, M., Hu, X., & Yin, H. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.986405 · Cited by 42
“However, it has been shown that HDACs can deacetylate and modulate cytokines other than histones to produce various biological effects (Chen et al., 2001; Hubbert et al., 2002; Simonsson et al., 2005).”
BackgroundJacob, A., Oblinger, J. L., Bush, M. L., Brendel, V. J., Santarelli, G. D., Chaudhury, A. R., Kulp, S. K., Perle, K. M. D. L., Chen, C., Chang, L., et al. (2011) · The Laryngoscope · doi:10.1002/lary.22392 · Cited by 45
HDAC6 Is a Bruchpilot Deacetylase that Facilitates Neurotransmitter Release
Miskiewicz, K., Jose, L. E., Yeshaw, W. M., Valadas, J. S., Swerts, J., Munck, S., Feiguin, F., Dermaut, B., & Verstreken, P. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.05.051 · Cited by 44
“While many HDAC-like proteins are present in the nucleus to deacetylate histones, HDAC6 predominantly locates to the cytoplasm, where it has been implicated in the modification of different proteins, including a-tubulin, contractin, and HSP90 (Hubbert et al., 2002; Kovacs et al., 2005; Zhang et al., 2007).”
BackgroundBelinostat: clinical applications in solid tumors and lymphoma
Molife, L. R., & Bono, J. S. D. (2011) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2011.629604 · Cited by 46
“HSP90 and a-tubulin is modulated by HDAC6 which is a known tubulin deacetylase [13,14].”
BackgroundDavis, F. J., Pillai, J. B., Gupta, M., & Gupta, M. P. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00789.2004 · Cited by 44
Kawada, J., Zou, P., Mazitschek, R., Bradner, J. E., & Cohen, J. I. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m809090200 · Cited by 43
Guichard, P., Laporte, M. H., & Hamel, V. (2021) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2021.12.001 · Cited by 43
Curriculum vitae of HDAC6 in solid tumors
Zheng, Y., Kang, H., Wang, B., Zhu, Y.-Z., Mamun, M., Zhao, L., Nie, H., Liu, Y., Zhao, L., Zhang, X., et al. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.123219 · Cited by 43
Epigenetic Regulation of HIV-1 Transcription
Tripathy, M. K., Abbas, W., & Herbein, G. (2011) · Epigenomics · doi:10.2217/epi.11.61 · Cited by 47
HDAC6 Promotes Cardiac Fibrosis Progression through Suppressing RASSF1A Expression
Tao, H., Yang, J., Hu, W. M., Shi, K., & Li, J. (2015) · Cardiology · doi:10.1159/000438781 · Cited by 43
Skoge, R. H., & Ziegler, M. (2016) · Journal of Cell Science · doi:10.1242/jcs.187518 · Cited by 46
“, 2002), whereas stable overexpression of HDAC6 reduced taxolinduced hyperacetylation (Hubbert et al., 2002).”
BackgroundInfluentialRuttala, H. B., Ramasamy, T., Poudal, B. K., Choi, Y., Choi, J. Y., Kim, J., Ku, S., Choi, H., Yong, C. S., & Kim, J. O. (2017) · Oncotarget · doi:10.18632/oncotarget.14742 · Cited by 44
CPT1A Supports Castration-Resistant Prostate Cancer in Androgen-Deprived Conditions
Joshi, M., Stoykova, G. E., Salzmann‐Sullivan, M., Dzieciątkowska, M., Liebman, L. N., Deep, G., & Schlaepfer, I. R. (2019) · Cells · doi:10.3390/cells8101115 · Cited by 44
“The increased lysine acetylation in OE cells in castrated (CSS) conditions was expected since excess acetyl-CoA is known to acetylate cytoplasmic proteins [46].”
BackgroundFunctional aspects of primary cilium in signaling, assembly and microenvironment in cancer
Wang, B., Liang, Z., & Liu, P. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.30117 · Cited by 47
Wattanathamsan, O., & Pongrakhananon, V. (2021) · Cancer Gene Therapy · doi:10.1038/s41417-021-00396-4 · Cited by 47
Wang, L., Moreira, É. A., Kempf, G., Miyake, Y., Esteves, B. I. O., Fahmi, A., Schaefer, J. V., Dreier, B., Yamauchi, Y., Alves, M. P., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110736 · Cited by 44
“Major substrates of HDAC6 are tubulin (Hubbert et al., 2002; Zhang et al., 2003), HSP90 (Kovacs et al.”
BackgroundSanda, T., Okamoto, T., Uchida, Y., Nakagawa, H., Iida, S., Kayukawa, S., Suzuki, T., Oshizawa, T., Suzuki, T., Miyata, N., et al. (2007) · Leukemia · doi:10.1038/sj.leu.2404902 · Cited by 43
Tavares, J., Ouaissi, A., Santarém, N., Séréno, D., Vergnes, B., Sampaio, P., & Cordeiro‐da‐Silva, A. (2008) · Biochemical Journal · doi:10.1042/bj20080666 · Cited by 51
Brain expression level and activity of HDAC6 protein in neurodegenerative dementia
Odagiri, S., Tanji, K., Mori, F., Miki, Y., Kakita, A., Takahashi, H., & Wakabayashi, K. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.11.034 · Cited by 43
Du, Y., Yang, X. M., Li, Z., Le, W., Hao, Y., Song, Y., Wang, F., & Guan, Y. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105141 · Cited by 43
Deng, Y., Gao, J., Xu, G., Yao, Y., Sun, Y., Shi, Y., Hao, X., Niu, L., & Li, H. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.215911 · Cited by 47
Huang, W., Chen, C., Chao, S.-W., Lee, S., Hsu, F., Lu, Y., Hung, M., & Chang, C. (2010) · ChemMedChem · doi:10.1002/cmdc.200900494 · Cited by 42
Grassadonia, A., Cioffi, P., Simiele, F., Iezzi, L., Zilli, M., & Natoli, C. (2013) · Cancers · doi:10.3390/cancers5030919 · Cited by 47
“Vorinostat has also been reported to synergize with taxanes through the inhibition of HDAC-6, responsible of α-tubulin de-acetylation [70].”
BackgroundNew, M., Olzscha, H., Liu, G., Khan, O., Stimson, L., McGouran, J. F., Kerr, D. J., Coutts, A. S., Kessler, B. M., Middleton, M. R., et al. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2013.47 · Cited by 45
Pyridylalanine‐Containing Hydroxamic Acids as Selective HDAC6 Inhibitors
Schäfer, S., Saunders, L., Schlimme, S., Valkov, V., Wagner, J. M., Kratz, F., Sippl, W., Verdin, E., & Jung, M. (2009) · ChemMedChem · doi:10.1002/cmdc.200800196 · Cited by 41
Biomarkers of head and neck cancer, tools or a gordian knot?
Lampri, E. S., Chondrogiannis, G., Ioachim, E. E., Varouktsi, A., Mitselou, A., Galani, A., Briassoulis, E., Kanavaros, P., & Galani, V. (2015) · PubMed · Cited by 50
Wright, L. H., & Menick, D. R. (2016) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00271.2016 · Cited by 43
Li, L., Li, K., Mao, Y., Qu, H., Yao, B., Zhong, W., Ma, B., & Wang, Z.-Y. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.4095 · Cited by 44
“Deregulation of HDAC6 activity is associated with a variety of diseases including cancer leading to a growing interest for developing HDAC6 inhibitors (25,26).”
Harding, R., de Freitas, R. F., Collins, P. M., Franzoni, I., Ravichandran, M., Ouyang, H., Juárez‐Ornelas, K. A., Lautens, M., Schapira, M., von Delft, F., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00933 · Cited by 41
Siegel, D. M., Dehn, D. L., Bokatzian, S. S., Quinn, K. D., Backos, D. S., Francesco, A. D., Bernier, M., Reisdorph, N. A., de Cabo, R., & Ross, D. (2018) · PLoS ONE · doi:10.1371/journal.pone.0190717 · Cited by 43
Wang, D., Li, W., Zhao, R., Chen, L., Liu, N., Tian, Y., Zhao, H., Xie, M., Lu, F., Fang, Q., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-1421 · Cited by 43
Mechanisms of extracellular vesicle uptake in stressed retinal pigment epithelial cell monolayers
Nicholson, C., Shah, N., Ishii, M., Annamalai, B., Brandon, C. S., Rodgers, J. I., Nowling, T. K., & Rohrer, B. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.165608 · Cited by 45
“In short, αtubulin is a substrate of HDAC6 [33, 34], its acetylation stabilizes microtubule structure [33, 35], overexpression of HDAC6 reduces α-tubulin acetylation [36], and tight junction stability in various endothelial [37, 38] and epithelial tissues [39, 40] was shown to improve in the presence of the HDAC6 inhi…”
BackgroundWu, Y., Wang, D., Fang, W., Xiong, F., Zhang, S., Gong, Z., Shi, L., Li, X., Xiang, B., Ma, J., et al. (2020) · The FASEB Journal · doi:10.1096/fj.202001508r · Cited by 42
Ma, C., Gao, J., Liang, J., Dai, W., Wang, Z., Xia, M., Chen, T., Huang, S., Na, J., Xu, L., et al. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02545-w · Cited by 44
“In this sense, tubastatin A belongs to such an ideal HDIs since it was reported substantially more selective (over 1000-fold selectivity) to inhibit HDAC6 than other isozymes except HDAC8 (57-fold selectivity) [27].”
BackgroundTargeting histone deacetylases for heart failure
Bush, E. W., & McKinsey, T. A. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220902939161 · Cited by 43
“First identified as a tubulin deacetylase [6], HDAC6 is closely associated with the other, less well-characterized class IIb HDAC, HDAC10 [4].”
HDAC6 regulates the dynamics of lytic granules in cytotoxic T lymphocytes
Núñez‐Andrade, N., Iborra, S., Trullo, A., Moreno-Gonzalo, O., Calvo, E., Catalán, E., Ménasché, G., Sancho, D., Vázquez, J., Yao, T., et al. (2016) · Journal of Cell Science · doi:10.1242/jcs.180885 · Cited by 44
“Histone deacetylase 6 (HDAC6) is a ubiquitous cytosolic protein from the class II HDACs family with X-linked inheritance, that binds to and deacetylates α-tubulin at Lys40 (Hubbert et al., 2002; Valenzuela-Fernandez et al., 2008).”
Self-citationRau, C., Kuo, P., Wu, S., Huang, L., Lu, T., Wu, Y.-C., Wu, C., Lin, C.-W., Tsai, C.-W., & Hsieh, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168545 · Cited by 44
“Members of the HDAC family deacetylate tubulin and actin cytoskeleton components, thus impacting neurite formation [42].”
BackgroundPrimary Cilia in Glial Cells: An Oasis in the Journey to Overcoming Neurodegenerative Diseases
Ki, S. M., Jeong, H. S., & Lee, J. E. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.736888 · Cited by 40
Dysferlin Interacts with Histone Deacetylase 6 and Increases alpha-Tubulin Acetylation
Fulvio, S. D., Azakir, B., Therrien, C., & Sinnreich, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028563 · Cited by 46
“HDAC6 has two catalytic hdac domains used to deacetylate alpha-tubulin [21,23,24], cortactin [23,25,26] and Hsp90 [27].”
RetractedThe small GTPase ARL2 is required for cytokinesis in Trypanosoma brucei
Price, H. P., Peltan, A., Stark, M., & Smith, D. F. (2010) · Molecular and Biochemical Parasitology · doi:10.1016/j.molbiopara.2010.05.016 · Cited by 45
Ritagliati, C., Alonso, V. L., Manarin, R., Cribb, P., & Serra, E. C. (2015) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0003725 · Cited by 49
“LiSIR2RP1 is also found associated with the cytoskeleton network and deacetylates α-tubulin, a function that resembles that of human SIRT2 and HDAC6.”
BackgroundInfluentialWang, Y., Yan, Z., Qi, Y., Cheng, B.-B., Wang, X.-D., Zhao, D., Shen, B., & Jiang, Z. (2010) · Annals of Biomedical Engineering · doi:10.1007/s10439-009-9896-6 · Cited by 42
Self-citationHistone deacetylases 1 and 2 are required for brain development
Jaworska, J., Ziemka‐Nałęcz, M., & Zalewska, T. (2015) · The International Journal of Developmental Biology · doi:10.1387/ijdb.150071tz · Cited by 47
“…et al. 2009a,b; Morrison et al. 2006; Kim and Bae 2011 Class IIb Zn2+ HDAC 6 Cytoplasm Viable; increased tubulin acetylation Hyperactive, anxiolytic Hubbert et al. 2002; Fukada et al. 2012; Pandey et al. 2007a,b; Dompierre et al. 2007; Rivieccio et al. 2009 HDAC 10 Cytoplasm NR NR Kao et al.…”
BackgroundThe role of Runx2 in facilitating autophagy in metastatic breast cancer cells
Tandon, M., Othman, A. H., Ashok, V., Stein, G. S., & Pratap, J. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.25916 · Cited by 43
“Our findings raise a possibility that dynamic interaction among Runx2, HDACs, and α-TAT-1 with α-tubulin could regulate acetylationofα-tubulin and thus affect theoutcomeof autophagy.”
BackgroundAmin, S. A., Adhikari, N., & Jha, T. (2017) · Future Medicinal Chemistry · doi:10.4155/fmc-2017-0130 · Cited by 45
“The HDAC-6 consists of two catalytic sites [18] along with a carboxyl terminus zinc finger motif while HDAC-10 comprises one active deacetylase domain and one incomplete domain [19].”
Chen, M.-C., Lin, Y., Liao, Y.-H., Liou, J., & Chen, C. (2019) · Cancers · doi:10.3390/cancers11101617 · Cited by 44
Pramanik, S. D., Halder, A. K., Mukherjee, U., Kumar, D., Dey, Y. N., & Mogana, R. (2022) · Frontiers in Chemistry · doi:10.3389/fchem.2022.948217 · Cited by 47
“Furthermore, elevated HDAC3 and HDAC6 expressions were found in CCA patients’ tissues, which were associated with a poor prognosis (Hubbert et al., 2002; Gradilone et al., 2013; Yin et al., 2017).”
BackgroundGrassi, E., Vezzoli, V., Negri, I., Lábadi, Á., Fugazzola, L., Vitale, G., & Persani, L. (2015) · Oncotarget · doi:10.18632/oncotarget.5799 · Cited by 42
“In a previous screening, SP significantly inhibited the activity of ROCK [38], a kinase recently described to control tubulin and β-catenin stability through their main deacetylating enzyme HDAC6 [39-41].”
BackgroundOlson, D. E., Sleiman, S. F., Bourassa, M. W., Wagner, F. F., Gale, J. P., Zhang, Y., Ratan, R. R., & Holson, E. B. (2015) · Chemistry & Biology · doi:10.1016/j.chembiol.2015.03.014 · Cited by 41
Ortore, G., Colo, F. D., & Martinelli, A. (2009) · Journal of Chemical Information and Modeling · doi:10.1021/ci900288e · Cited by 40
Nadeem, L., Brkić, J., Chen, Y. F., Bui, T., Munir, S., & Peng, C. (2012) · Journal of Cell Science · doi:10.1242/jcs.110197 · Cited by 40
Creating a “Prosurvival Phenotype” Through Histone Deacetylase Inhibition: Past, Present, and Future
Halaweish, I. F., Nikolian, V. C., Georgoff, P. E., Li, Y., & Alam, H. B. (2015) · Shock · doi:10.1097/shk.0000000000000319 · Cited by 45
“Histone deacetylase 6 overexpression results in tubulin deacetylation and increased cell motility (68, 69), whereas specific inhibition or downregulation of HDAC6 activity increases acetylation of !tubulin and HSP90, leading to reduced cellular motility and degradation of HSP90 client proteins, such as Bcr-Abl, Raf-1,…”
BackgroundGanai, S. A. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.04.022 · Cited by 41
A Rational Approach for the Identification of Non-Hydroxamate HDAC6-Selective Inhibitors
Goracci, L., Deschamps, N., Randazzo, G. M., Petit, C., Passos, C. D. S., Carrupt, P., Simões‐Pires, C. A., & Nurisso, A. (2016) · Scientific Reports · doi:10.1038/srep29086 · Cited by 43
Dissecting the role of the tubulin code in mitosis
Ferreira, L. T., Figueiredo, A. C., Orr, B., Lopes, D., & Maiato, H. (2018) · Methods in cell biology · doi:10.1016/bs.mcb.2018.03.040 · Cited by 43
Suppressor of hepatocellular carcinoma RASSF1A activates autophagy initiation and maturation
Li, W., Yue, F., Dai, Y., Shi, B., Xu, G., Jiang, X., Zhou, X., Pfeifer, G. P., & Liu, L. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0211-7 · Cited by 42
Wang, H., Zhang, Y., Tang, F., Pan, M., Wan, X., Li, X., & Sun, S. (2019) · Development · doi:10.1242/dev.171280 · Cited by 39
“The acetyltransferases αTAT and Nat10 reportedly participate in acetylation of tubulin, whereas the deacetylases Hdac6 and Sirt2 are related to deacetylation of tubulin in somatic cells and oocytes (Coombes et al., 2016; Hubbert et al., 2002; Larrieu et al., 2014; Zhang et al., 2014a).”
BackgroundProtein Quality Control Activation and Microtubule Remodeling in Hypertrophic Cardiomyopathy
Dorsch, L. M., Schuldt, M., dos Remedios, C. G., Schinkel, A. F. L., de Jong, P. L., Michels, M., Kuster, D. W. D., Brundel, B. J. J. M., & van der Velden, J. (2019) · Cells · doi:10.3390/cells8070741 · Cited by 43
“Acetylation of α-tubulin is associated with stable microtubules and is used as a marker of their stability [65,66].”
BackgroundYamauchi, Y. (2020) · Advances in virus research · doi:10.1016/bs.aivir.2020.01.001 · Cited by 51
Celen, S., Rokka, J., Gilbert, T. M., Koole, M. J. B., Vermeulen, I., Serdons, K., Schroeder, F. A., Wagner, F. F., Bleeser, T., Hightower, B. G., et al. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00074 · Cited by 41
HDAC6 ZnF UBP as the Modifier of Tau Structure and Function
Balmik, A. A., Chidambaram, H., Dangi, A., Marelli, U. K., & Chinnathambi, S. (2020) · Biochemistry · doi:10.1021/acs.biochem.0c00585 · Cited by 40
Singh, A., Chang, T.-Y., Kaur, N., Hsu, K., Yen, Y., Lin, T. E., Lai, M.-J., Lee, S., & Liou, J. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113169 · Cited by 39
The Role of Spastin in Axon Biology
Costa, A. C., & Sousa, M. M. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.934522 · Cited by 45
“, 2010) and the deacetylating enzymes histone deacetylase 6 (HDAC6) and sirtuin 2 (SIRT2) (Hubbert et al., 2002; North et al., 2003).”
BackgroundHan, S.-W., & Ryu, K. (2022) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2022.129576 · Cited by 41
The Biology and Therapeutic Implications of HDACs in the Heart
McKinsey, T. A. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-21631-2_4 · Cited by 41
“HDAC6 is a microtubule deacetylase (Hubbert et al. 2002), and microtubules comprise a major component of the cardiomyocyte cytoskeleton.”
BackgroundEwens, C. A., Kloppsteck, P., Förster, A., Zhang, X., & Freemont, P. S. (2010) · Biochemistry and Cell Biology · doi:10.1139/o09-128 · Cited by 39
SIRT2 regulates nuclear envelope reassembly through ANKLE2 deacetylation
Kaufmann, T., Kukolj, E., Brachner, A., Beltzung, E., Bruno, M., Kostrhon, S., Opravil, S., Hudecz, O., Mechtler, K., Warren, G., et al. (2016) · Journal of Cell Science · doi:10.1242/jcs.192633 · Cited by 43
Class II and IV HDACs function as inhibitors of osteoclast differentiation
Blixt, N. C., Faulkner, B., Astleford, K., Lelich, R., Schering, J., Spencer, E., Gopalakrishnan, R., Jensen, E. D., & Mansky, K. C. (2017) · PLoS ONE · doi:10.1371/journal.pone.0185441 · Cited by 48
p27Kip1 Modulates Axonal Transport by Regulating α-Tubulin Acetyltransferase 1 Stability
Morelli, G., Even, A., Gladwyn-Ng, I., Le Bail, R., Shilian, M., Godin, J. D., Peyre, E., Hassan, B. A., Besson, A., Rigo, J.-M., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.04.083 · Cited by 39
“Treatment with the selective HDAC6 inhibitor tu- bastatin (TBA, 10 mM) (Butler et al., 2010) rescued MT-acetylation-level in cultured p27Kip1 KO neurons (Figures 3A and 3B).”
BackgroundInfluentialAdvancements in Host-Based Interventions for Influenza Treatment
Yip, T.-F., Selim, A. S. M. M., Lian, I., & Lee, S. M.-Y. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01547 · Cited by 39
“Histone deacetylase 6 (HDAC6) was found to deacetylate α-tubulin, one of the subunits of microtubule (119).”
BackgroundHDAC6 Regulates the MRTF-A/SRF Axis and Vascular Smooth Muscle Cell Plasticity
Zhang, M., Urabe, G., Little, C. J., Wang, B., Kent, A. M., Huang, Y., Kent, K. C., & Guo, L. (2018) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2018.08.010 · Cited by 41
“HDAC6 is unique among all HDACs not only because it is primarily located in the cytosol but also for its well-established function in tubulin deacetylation and hence microtubule destabilization (4).”
BackgroundInfluentialYan, Y., Wang, H., Wei, C., Xiang, Y., Liang, X., Phang, C.-W., & Jiao, R. (2019) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2019.03.008 · Cited by 40
Qiu, W., Wang, B., Gao, Y., Tian, Y., Tian, M., Chen, Y., Xu, L. M., Yao, T., Li, P., & Yang, P. (2019) · Hepatology · doi:10.1002/hep.30960 · Cited by 40
“The deacetylase activity was indicated by the decreased acetylation level of α-tubulin, a well-recognized substrate of HDAC6.(22) Furthermore, CD4+ T cells treated with tubacin, an HDAC6-specific inhibitor, displayed an elevated mRNA expression of Il17a and Il17f (Fig.”
BackgroundInfluentialSelf-citationYou, D., Richardson, J. R., & Aleksunes, L. M. (2020) · Drug Metabolism and Disposition · doi:10.1124/dmd.119.089953 · Cited by 41
Hanif, M., Arshad, J. Z., Astin, J. W., Rana, Z., Zafar, A., Movassaghi, S., Leung, E. Y., Patel, K. D., Söhnel, T., Reynisson, J., et al. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202005758 · Cited by 42
El-Saiy, K. A., Sayed, R. H., El-Sahar, A. E., & Kandil, E. A. (2022) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2022.109841 · Cited by 39
Bär, J., Popp, Y., Bucher, M., & Mikhaylova, M. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2022.119241 · Cited by 43
Mosley, A. J., Meekings, K. N., McCarthy, C., Shepherd, D., Cerundolo, V., Mazitschek, R., Tanaka, Y., Taylor, G. P., & Bangham, C. R. (2006) · Blood · doi:10.1182/blood-2006-03-013235 · Cited by 39
Chaperoning steroid hormone signaling via reversible acetylation
Kovacs, J. J., Cohen, T. J., & Yao, T. (2005) · Nuclear Receptor Signaling · doi:10.1621/nrs.03004 · Cited by 39
“For example, the characterization of HDAC6 has implicated protein acetylation in the regulation of microtubule dynamics, growth factor-induced chemotaxis and the processing of misfolded protein aggregates [Hubbert et al., 2002; Haggarty et al., 2003] .”
BackgroundSelf-citationWang, A. H., Grégoire, S., Zika, E., Xiao, L., Li, C. S., Li, H., Wright, K. L., Ting, J. P. ‐., & Yang, X. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500295200 · Cited by 48
Michael, B. (2004) · Frontiers in bioscience · doi:10.2741/1417 · Cited by 43
“Among these, histone deacetylase-6 (124, 125) and nuclear receptor coactivator 3 (CBP interacting protein) (126-128) with histone acetyltransferase and pCAF/CBP recruiting abilities are particularly interesting, since p30 contains multiple highly conserved lysines, which could play a role in acetylation.”
BackgroundMicrotubule Destabilization Paves the Way to Parkinson’s Disease
Cartelli, D., & Cappelletti, G. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0188-5 · Cited by 48
“deacetylase 6, HDAC6) [93] MTs could represent a potential target for therapy.”
BackgroundJayne, S., Zwartjes, C. G. M., Van Schaik, F. M. A., & Timmers, H. T. M. (2006) · Biochemical Journal · doi:10.1042/bj20060406 · Cited by 39
PROTACs in Epigenetic Cancer Therapy: Current Status and Future Opportunities
Liu, X., Wang, A., Shi, Y., Dai, M., Liu, M., & Cai, H. (2023) · Molecules · doi:10.3390/molecules28031217 · Cited by 38
“HDAC6 is a class IIb HDAC that is mainly expressed in the cytoplasm and is responsible for the deacetylation of cytoplasmic proteins and regulating the turnover of misfolded and polyubiquitinated proteins [91,92].”
BackgroundChatterjee, N., Wang, W. W., Conklin, T., Chittur, S. V., & Tenniswood, M. (2013) · Cancer Biology & Therapy · doi:10.4161/cbt.25088 · Cited by 38
Huang, W., Chen, C., Chao, S.-W., Yu, C.-C., Yang, C., Guh, J., Lin, Y.-C., Kuo, C.-I., Yang, P., & Chang, C.-I. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.06.002 · Cited by 39
Endicott, S. J., Basu, B., Khokha, M. K., & Brueckner, M. K. (2015) · Development · doi:10.1242/dev.126953 · Cited by 44
Lee, D. H., Won, H.-R., Ryu, H.-W., Han, J. M., & Kwon, S. H. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4405 · Cited by 38
Metadata
- Authors
- Hubbert, C., Guardiola, A., Shao, R., Kawaguchi, Y., Ito, A., Nixon, A., Yoshida, M., Wang, X.-F., & Yao, T.-P.
- Affiliations
- Duke University (US)
- Japan Science and Technology Agency (JP)
- Corresponding author
- Yao, Tso-Pang
- Venue
- Nature
- Published
- 2002-05
- Volume
- 417
- Issue
- 6887
- Pages
- 455-458
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2064959533
- Cited by
- 2,403
- References
- 21
- Citations by year
- 2026: 96 · 2025: 116 · 2024: 116 · 2023: 126 · 2022: 117 · 2021: 139 · 2020: 130 · 2019: 122 · 2018: 112 · 2017: 102 · 2016: 102 · 2015: 117 · 2014: 119 · 2013: 117 · 2012: 122
- FWCI
- 15.94
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- U.S. Department of Defense
- Damon Runyon Cancer Research Foundation
- World Bank Group
- Robert Bosch Stiftung
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- HDAC6, alpha-tubulin acetylation, microtubule stability, p150Glued, cell motility, chemotaxis, histone deacetylase
- MeSH terms
- Histone Deacetylase 6, Acetylation, Animals, Chemotaxis, Histone Deacetylases, Microtubule-Associated Proteins, Microtubules, Protein Binding, Tubulin, 3T3 Cells, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.